English
Français
Deutsch
Italiano
Português
Русский
Español
简体中文
日本語
Max Helfert is a Master’s in Finance student at USC, pursuing a career in equity research. He specializes in healthcare innovation, leveraging a bottom-up approach to identify high-growth opportunities and mispriced assets.With a strong foundation in financial modeling and valuation, Max provides in-depth research into investment opportunities and market trends. His GARP investing style blends deep company-specific analysis with a broader industry perspective, allowing him to identify businesses with sustainable moats and long-term growth potential.Stay up to date with Max’s latest thoughts and investment insights by following him on X (@maxwellhelfert).
Analyst’s Disclosure: I/we have a beneficial long position in the shares of TMDX either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Read the full article here
